HBV and Moms-to-Be

 

If you have not been infected, get vaccinated

Hepatitis B can still be transmitted through unprotected sex and contaminated blood (sharing toothbrushes, razors, or needles for tattoos/piercings).

The 3 shots given over 6 months are safe, even during pregnancy.  The hepatitis B vaccine is so effective in preventing HBV and liver cancer that it is known as the first “anti-cancer vaccine.”


Make sure your baby is vaccinated at birth

Since 1991, U.S. national guidelines have recommended that all newborns be vaccinated against HBV.  The 3 shots can protect your baby for life against hepatitis B, reducing the risk of liver cancer  and liver damage in the future.

Infant should receive
 
At birth
birth dose of hepatitis B vaccine
 
1-2 months
2nd dose of hepatitis B vaccine
 
6 months
3rd dose of hepatitis B vaccine
 


The vaccine is safe, even for premature babies.

 

HBV and Moms-to-Be

Hepatitis B (HBV) is the most common serious viral infection of the liver, and can lead to premature death from liver cancer or liver failure.

In the U.S., approximately 10-15 people die  every day as a result of HBV infection.

Hepatitis B can be transmitted from an infected mother to her child during the birthing process.

Newborns who become infected with HBV have a 90% chance of developing chronic (lifelong) infection.

Fortunately, HBV can be prevented with a very safe and effective vaccine.

Ask your doctor for the results of your HBV test

Most people with chronic HBV infection have no symptoms.  As an expecting mother, you should have already been tested for HBV with the following blood test:

Hepatitis B surface antigen (HBsAg):
Tells if you have chronic hepatitis B (also known as being a hepatitis B carrier).

 


During pregnancy:
Currently, antiviral HBV treatments are not recommended during pregnancy.  If you are already on treatment, talk to your doctor.

At time of birth:
In addition to the first shot of the hepatitis B vaccine, make sure your newborn receives the hepatitis B immunoglobulin (HBIG) shot.

Infant born to mother with HBV should receive

At birth
birth dose of hepatitis B vaccine and hepatitis B immunoglobulin (HBIG)
 
1-2 months
2nd dose of hepatitis B vaccine
 
6 months
3rd dose of hepatitis B vaccine
 
9-18 months
HBsAg and anti-HBs* tests to confirm that your child is protected
 


* The hepatitis B surface antibody (anti-HBs) blood test checks for protection against HBV.

Cesarean sections (C-sections) have not been found to prevent HBV transmission from mother to child.  Hepatitis B vaccination along with the HBIG shot is the best way to protect your newborn against HBV infection.

In the first 6 months:
It is critical for your child to complete the hepatitis B vaccine series on time.  This will be more than 95% effective in protecting your newborn against HBV infection.

Breastfeeding is safe for your baby.  HBV is not transmitted through breast milk.

 

Remember to get screened for liver disease
You probably have no symptoms and feel healthy, but are still at increased risk for liver damage or liver cancer.  However, regular screening and appropriate treatment can reduce this risk and help you lead a normal, healthy life.  Ask your doctor for the following tests:
 
Every 6 months:
ALT blood test
Tests for liver damage
 
AFP blood test
Tests for liver cancer
 
Every year:
Ultrasound
Tests for liver cancer
 


Don’t rush into treatment
Not every person with chronic HBV infection needs treatment.  But if your ALT level is elevated, treatment with antiviral medication may be appropriate.

Be sure to review all medications with your doctor.  Even some over-the-counter or herbal medications can injure your liver.
Get the hepatitis A vaccine

Avoid drinking alcohol

Protect your loved ones

Make sure your family and partner are tested for HBV, and vaccinated if they are not already protected.

Your local health department may contact you to ensure your baby is fully protected against HBV.

 

 


 

 

Latest Hepatitis B News
Impressive Vertex hepatitis C drug data unveiled

November 1, 2008 - A closely watched hepatitis C treatment being developed by Vertex Pharmaceuticals Inc showed an impressive ability to knock out the virus in patients who failed other treatments and those not previously treated for the serious liver disease, data from mid-stage studies show.

U.S. hepatitis A vaccine rates vary widely

January 25, 2012 — NEW YORK (Reuters Health) - Although about 85 percent of kids in two U.S. states have had a complete set of hepatitis A vaccines, overall just three in 10 have had both shots, according to a new survey from the Centers for Disease Control and Prevention (CDC).

Most toddler vaccines not linked to blood disease

January 10, 2012 — NEW YORK (Reuters Health) - Although the MMR vaccine has been linked to a heightened risk of a rare blood disorder, other childhood vaccines do not appear to be, researchers reported Monday.

New DNA reader to bring genetics to clinics

January 10, 2012 — NEW YORK (Reuters) - A new DNA reader could bring genetics to medical clinics.

Select news items provided by Reuters Health